Navigation Links
New £340,000 investment into asthma and allergy research at University of Leicester
Date:6/26/2012

A charity operating Britain's longest-running pollen database is investing over 340,000 into vital asthma and allergy research at the University of Leicester.

The Midlands Asthma and Allergy Research Association (MAARA), a local charity established in 1968 to undertake and fund research into the causes of asthma and allergy, is funding the study in the University's Department of Infection, Immunity and Inflammation.

Steve Watson, Chairman of MAARA, said: "We recognise the importance of research in this area and have been impressed with the results that Dr Pashley and her team have delivered to date. I believe that the techniques they have developed are ground breaking and the results of the longer term research could make a real difference to the lives of Asthma sufferers."

The funding will directly benefit asthma and hayfever sufferers in the East Midlands, according to Dr Catherine Pashley who runs the aerobiology and clinical mycology group at the University. She said: "I am absolutely delighted to be given this amazing opportunity. This funding means we will be able to continue our research which we hope will enable us to better understand what fungi people are breathing in, and which of these fungi are causing clinical complications. We hope to also begin new strands of research that will help us to better understand the mechanisms behind how the fungi are causing problems."

In 2005, MAARA provided a five year start-up grant to the University of Leicester, under the leadership of Professor Andy Wardlaw, to establish the new Aerobiology and clinical mycology group.

MAARA also fund the University of Leicester aerobiology and clinical mycology group as the only site in the East Midlands recording airborne pollen levels, a summary of which is made freely available on the MAARA website in addition to being used by the Met. office in conjunction with other sites throughout the UK to produce pollen forecasts for hayfever sufferers.

The group is also one of only two sites in the UK routinely recording airborne fungal spore levels. With access to the MAARA aerobiology database which goes back to 1970, the group has the longest running pollen and fungal spore database in the UK. The funding also helped initiate a programme of research into the role of fungal allergy in asthma, which has resulted in six research articles published to date in peer reviewed journals, including one in a top respiratory journal.

Fungal allergy affects a significant proportion of hayfever and asthma sufferers, but our understanding of which fungi are involved and how they cause problems is still mostly unknown. With the support of MAARA researchers at the University of Leicester are actively learning more about the fungi in the air we breathe indoors and out. In addition they are taking a closer look at which fungi are actively growing in the lungs of people with asthma, and are currently involved in a clinical trial looking at the effectiveness of an antifungal treatment.

Dr Pashley added: "A better understanding will hopefully allow us to advise people with allergies about living conditions and how to manage their allergies. In the long term there is the hope of treatments that will prevent the fungal allergies themselves rather than just treating the symptoms."


'/>"/>

Contact: Dr. Catherine Pashley
44-116-252-2936
University of Leicester
Source:Eurekalert  

Related medicine news :

1. EB-5 Expert Brian Su Explores Chinese Inbound Investments in Southern California
2. San Francisco EB-5 Conference explores inbound Chinese investments
3. Artisan Hosts US China India Investment Event August 23-24, 2012
4. Rapid Asthma Treatment in ER May Prevent Admission
5. Some Schools Dont Let Kids Carry Asthma Inhalers
6. Secondhand smoke continues to vex children with asthma
7. Many Asthmatic Kids Harmed by Secondhand Smoke: Study
8. Seniors Undertreated for Asthma, and Many Skip Inhalers: Study
9. ICU stays for worst asthma drop 74 percent, review finds
10. Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study
11. Asthma Cases Continue to Rise in U.S., Affecting Millions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New £340,000 investment into asthma and allergy research at University of Leicester
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: